Skip Navigation
Skip to contents
Results by Year

View Wide

Filter

ARTICLE TYPE

more+
SELECT FILTER
 
Close

PUBLICATION DATE

171 results
Display

An implementation of the learning curve cumulative summation test to evaluate a practicum for endometrial cancer ultrasound staging

Xholli A, Londero AP, Jakimovska M, Zermano S, Puma L, Pasqual EM, Kobal B, Cagnacci A

Purpose: The learning curve cumulative summation (LC-CUSUM) test is commonly used as a quantitative assessment of the individual learning process. This study aimed to evaluate the skill acquisition process for...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Triphenyl phosphate activates estrogen receptor α/NF-κB/ cyclin D1 signaling to stimulate cell cycle progression in human Ishikawa endometrial cancer cells

Kwon HY, Park SB, Han M, Park JW, Lee Y, Han Sj, Kwon Y, Cho YJ

Objective Triphenyl phosphate (TPHP) is one of the most commonly used organophosphorus flame retardants that may accumulate in the environment. However, its effects on human reproductive organs have not been well...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Randomized comparison between sentinel lymph node mapping using indocyanine green plus a fluorescent camera versus lymph node dissection in clinical stage I-II endometrial cancer: a Korean Gynecologic Oncology Group trial (KGOG2029/SELYE)

Park JY, Kim JH, Baek MH, Park E, Kim SW

Background Sentinel lymph node (SLN) mapping has been suggested as an alternative surgical technique to full lymphadenectomy for early-stage endometrial cancer. However, the survival outcomes of SLN mapping compared with lymphadenectomy...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Sentinel lymph node biopsy in high-risk endometrial cancer: performance, outcomes, and future avenues

Kim YN, Kim YT

Endometrial cancer is the second most common gynecological malignancy worldwide, with an overall favorable prognosis. However, a subgroup of patients has a high risk of recurrence and poor prognosis. This...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
The added value of SLN mapping with indocyanine green in low- and intermediate-risk endometrial cancer management: a systematic review and meta-analysis

Burg LC, Verheijen S, Bekkers RL, IntHout J, Holloway RW, Taskin S, Ferguson SE, Xue Y, Ditto A, Baiocchi G, Papadia A, Bogani G, Buda A, Kruitwagen RF, Zusterzeel PL

Objective The aim of this study was to assess the SLN detection rate in presumed early stage, low- and intermediate-risk endometrial cancers, the incidence of SLN metastases, and the negative predictive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Endometrial thickness and uterine artery Doppler parameters as soft markers for prediction of endometrial cancer in postmenopausal bleeding women: a cross-sectional study at tertiary referral hospitals from Vietnam

Nguyen PN, Nguyen VT

Objective To determine the value of endometrial thickness (ET) and Doppler indices of uterine artery (UtA) as sonographic markers in predicting endometrial cancer (EC) among postmenopausal bleeding (PMB) women in low-resource...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Management of inoperable endometrial cancer

Pitakkarnkul S, Chanpanitkitchot S, Tangjitgamol S

Some endometrial cancer (EMC) patients are not good candidates for primary surgery. The three major types of treatment for inoperable EMC are radiation therapy, chemotherapy, or their combination as neoadjuvant...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Improving locoregional outcome in high-intermediate-risk and high-risk stage I endometrial cancer with surgical staging followed by brachytherapy

Abakay CD, Arslan S, Kurt M, Cetintas S

Purpose: This study aims to assess the locoregional efficacy of postoperative vaginal brachytherapy (VBT) alone in patients undergoing surgical staging for early-stage high-intermediate-risk (HIR) and high-risk (HR) endometrial cancer. Materials...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Genomic landscape of advanced endometrial cancer analyzed by targeted next-generation sequencing and the cancer genome atlas (TCGA) dataset

Hong JH, Cho HW, Ouh YT, Lee JK, Chun Y, Gim JA

Objective Recent studies have detailed the genomic landscape of endometrial cancer (EC); however, no study has focused on genetic alterations in advanced EC. We performed genomic profiling of patients with advanced...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Conditional relative survival of patients with endometrial cancer: a Korean National Cancer Registry study

Shin DW, Jung KW, Ha J, Bae J

Objective The purpose of this study was to estimate 5-year conditional relative survival (5Y CRS) rates of endometrial cancer (EC) in Korea accounting for time already survived. Subgroup-specific estimates stratified by...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Clinical evaluation of a droplet digital PCR assay for detecting POLE mutations and molecular classification of endometrial cancer

Kim G, Lee SK, Suh DH, Kim K, No JH, Kim YB, Kim H

Objective We evaluated droplet digital polymerase chain reaction (ddPCR) method for detecting POLE mutations in endometrial cancer (EC) and guiding its molecular classification. Methods We reviewed 240 EC specimens from our hospital database....
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
One-step nucleic acid amplification (OSNA) assay for detecting lymph node metastasis in cervical and endometrial cancer: a preliminary study

Togami S, Ushiwaka T, Kitazono I, Yanazume S, Kamio M, Tanimoto A, Kobayashi H

Objective To evaluate the accuracy of the one-step nucleic acid amplification (OSNA) assay for the diagnosis of lymph node (LN) metastasis in uterine cancer. Methods A total of 116 LNs from 30 patients...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Characteristics and patterns of care of endometrial cancer before and during COVID-19 pandemic

Bogani G, Scambia G, Cimmino C, Fanfani F, Costantini B, Loverro M, Ferrandina G, Landoni F, Bazzurini L, Grassi T, Vitobello D, Siesto G, Perrone AM, Zanagnolo V, De Iaco P, Multinu F, Ghezzi F, Casarin J, Berretta R, Capozzi VA, Zupi E, Centini G, Pellegrino A, Corso S, Stevenazzi G, Montoli S, Boschi AC, Comerci G, Greco P, Martinello R, Sopracordevole F, Giorda G, Simoncini T, Caretto M, Sartori E, Ferrari F, Cianci A, Sarpietro G, Matarazzo MG, Zullo F, Bifulco G, Morelli M, Ferrero A, Biglia N, Barra F, Ferrero S, Maggiore ULR, Cianci S, Chiantera V, Ercoli A, Sozzi G, Martoccia A, Schettini S, Orlando T, Cannone FG, Ettore G, Puppo A, Borghese M, Martinelli C, Muzii L, Donato VD, Driul L, Restaino S, Bergamini A, Candotti G, Bocciolone L, Plotti F, Angioli R, Mantovani G, Ceccaroni M, Cassani C, Dominoni M, Giambanco L, Amodeo S, Leo L, Thomasset R, Raimondo D, Seracchioli R, Malzoni M, Gorlero F, Luca MD, Busato E, Kilzie S, Dell'Acqua A, Scarfone G, Vercellini P, Petrillo M, Dessole S, Capobianco G, Ciavattini A, Carpini GD

Objective Coronavirus disease 2019 (COVID-19) outbreak has correlated with the disruption of screening activities and diagnostic assessments. Endometrial cancer (EC) is one of the most common gynecological malignancies and it is...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Circular RNA intraflagellar transport 80 facilitates endometrial cancer progression through modulating miR-545-3p/FAM98A signaling

Wang N, Guo Y, Song L, Tong T, Fan X

Objective Endometrial cancer (ECa) is a common gynecological malignancy. Circular RNAs (circRNAs) have been identified as key regulators of human tumorigenesis and development. Herein, we explored the role and mechanism of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Association between hospital treatment volume and survival of women with gynecologic malignancy in Japan: a JSOG tumor registry-based data extraction study

Machida H, Matsuo K, Oba K, Aoki D, Enomoto T, Okamoto A, Katabuchi H, Nagase S, Mandai M, Yaegashi N, Yamagami W, Mikami M

Objective Associations between hospital treatment volume and survival outcomes for women with 3 types of gynecologic malignancies, and the trends and contributing factors for high-volume centers were examined. Methods The Japan Society of...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Knockdown of LKB1 Sensitizes Endometrial Cancer Cells via AMPK Activation

Rho SB, Byun HJ, Kim BR, Lee CH

Metformin is an anti-diabetic drug and has anticancer effects on various cancers. Several studies have suggested that metformin reduces cell proliferation and stimulates cell-cycle arrest and apoptosis. However, the definitive...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Rate of premalignant and malignant endometrial lesion in “low-risk” premenopausal women with abnormal uterine bleeding undergoing endometrial biopsy

Jha S, Singh A, Sinha HH, Bhadani P, Anant M, Agarwal M

Objective To determine the incidence of endometrial hyperplasia and endometrial cancer (EH/EC) in low-risk premenopausal women with abnormal uterine bleeding (AUB) undergoing endometrial biopsy and to build a predictive model that...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Stage one endometrioid endometrial adenocarcinoma: is there a role of traditional hospital follow-up in the detection of cancer recurrence in women after treatment?

Nikolopoulos M, Godfrey MA, Sohrabi F, Wong M, Bhatte D, Wuntakal R

Objective To investigate the rate of asymptomatic recurrence of stage 1 endometrioid endometrial cancer and assess the role of routine hospital follow-up after treatment. Methods We performed a retrospective case-note review...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
Vaginal cancer as a late complication of radiotherapy for endometrial cancer and ileo-perineal fistula after total pelvic exenteration

Comba C, Topaktas M, Bozkurt H, Erbin A, Ozdogan B, Demir O

Pelvic exenteration is a highly morbid operation and remains one of the most catastrophic surgical procedures in gynecological oncology. We would like to present the case of total pelvic exenteration...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close
A phase II, open-labeled, single-arm study of dose-dense paclitaxel plus carboplatin in advanced or recurrent uterine endometrial cancer treatment: a KCOG-G1303, DOENCA trial

Hori K, Nishio S, Ushijima K, Kasamatsu Y, Kondo E, Takehara K, Ito K

Objective To determine the safety and efficacy of dose-dense (dd) paclitaxel (PTX) and carboplatin (CBDCA) in treating advanced or recurrent endometrial cancer. Methods Women aged 20–75 years with histologically confirmed endometrial cancer, the...
CITED
export Copy
Close
SHARE
Twitter Facebook
Close

Go to Top

Copyright © 2023 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr